GLP-1 Receptor Agonists Reduce the Risk of Hepatocellular Carcinoma and Cirrhosis in Patients With Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

被引：0
|
作者：
Alsakarneh, Saqr [1 ]
Madi, Mahmoud [2 ]
Abuassi, Mohammad [3 ]
Jaber, Fouad [1 ]
Khadra, Majd [4 ]
Numan, Laith [2 ]
Syn, Wing-Kin [2 ]
机构：
[1] Univ Missouri, Kansas City Sch Med, Kansas City, MO USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
[3] Univ Cent Florida, HCA Healthcare GME, Gainesville, FL USA
[4] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036968.88400.f3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1900
引用
收藏
页码：S1364 / S1364
页数：1
相关论文
共 50 条
  • [31] Hepatocellular carcinoma can occur in non-alcoholic fatty liver disease without cirrhosis
    Leung, C.
    Yeoh, S.
    Patrick, D.
    Ket, S.
    Marion, K.
    Gow, P.
    Angus, P. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 76 - 76
  • [32] Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
    Ertle, Judith
    Dechene, Alexander
    Sowa, Jan-Peter
    Penndorf, Volker
    Herzer, Kerstin
    Kaiser, Gernot
    Schlaak, Joerg F.
    Gerken, Guido
    Syn, Wing-Kin
    Canbay, Ali
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) : 2436 - 2443
  • [33] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [34] Effect of GLP-1 on diet induce non-alcoholic fatty liver disease in rats
    Gao, Huiting
    Xu, Lishu
    Guan, Lichang
    Li, Dongfeng
    Deng, Weiping
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 851 - 851
  • [35] Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
    Bashar Mohamad
    Vaishal Shah
    Mykola Onyshchenko
    Mohammed Elshamy
    Federico Aucejo
    Rocio Lopez
    Ibrahim A. Hanouneh
    Razan Alhaddad
    Naim Alkhouri
    Hepatology International, 2016, 10 : 632 - 639
  • [36] Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
    Mohamad, Bashar
    Shah, Vaishal
    Onyshchenko, Mykola
    Elshamy, Mohammed
    Aucejo, Federico
    Lopez, Rocio
    Hanouneh, Ibrahim A.
    Alhaddad, Razan
    Alkhouri, Naim
    HEPATOLOGY INTERNATIONAL, 2016, 10 (04) : 632 - 639
  • [37] Hepatocellular Carcinoma in Patient With Non-Alcoholic Fatty Liver Without Cirrhosis
    Rapoport, Grigoriy
    Castano, Juan
    Al Jobori, Hussein
    Nathani, Muhammed Gulzar
    Patil, Rashmee
    Zamir, Asif
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1332 - S1332
  • [38] Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Resuli, B.
    Agaci, F.
    Kraja, B.
    Sema, K.
    Dhigoi, N.
    Kapia, M.
    Burda, I.
    DIABETOLOGIA, 2010, 53
  • [39] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [40] Comments on "Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes"
    Wei, James cheng-chung
    Wu, Ching-nung
    Cheng, Wei-chun
    GASTROENTEROLOGY, 2025, 168 (02) : 424 - 424
12345